D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
DCPH holding history
Deciphera Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DCPH overviewAll 13F holders of DCPHFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −506,384−100.0% | Sold out | Holders |
| Q1 2024 | 506,384 | $7.97M | <0.1% | +117,721+30.3% | Added | Holders |
| Q4 2023 | 388,663 | $6.27M | <0.1% | +71,702+22.6% | Added | Holders |
| Q3 2023 | 316,961 | $4.03M | <0.1% | −64,851−17.0% | Reduced | Holders |
| Q2 2023 | 381,812 | $5.38M | <0.1% | −408,974−51.7% | Reduced | Holders |
| Q1 2023 | 790,786 | $12.2M | <0.1% | −207,707−20.8% | Reduced | Holders |
| Q4 2022 | 998,493 | $16.4M | <0.1% | +208,082+26.3% | Added | Holders |
| Q3 2022 | 790,411 | $14.6M | <0.1% | +623,526+373.6% | Added | Holders |
| Q2 2022 | 166,885 | $2.19M | <0.1% | +102,991+161.2% | Added | Holders |
| Q1 2022 | 63,894 | $592.0K | <0.1% | −76,014−54.3% | Reduced | Holders |
| Q4 2021 | 139,908 | $1.37M | <0.1% | +139,908 | New | Holders |